The Chart of the Day is Incyte Corp (INCY). Since the Trend Spotter signaled a buy on 10/16 the stock gained 68.47%.
INCY is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. INCY also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.
Please share this article
No comments:
Post a Comment